| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Regulatory Networks | 43 | 2024 | 1743 | 6.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 88 | 2016 | 3777 | 4.670 |
Why?
|
| Databases, Genetic | 39 | 2022 | 1741 | 4.070 |
Why?
|
| Gene Expression Profiling | 115 | 2024 | 9417 | 3.890 |
Why?
|
| Computational Biology | 62 | 2023 | 3499 | 3.530 |
Why?
|
| Software | 39 | 2023 | 4431 | 2.920 |
Why?
|
| Expressed Sequence Tags | 28 | 2010 | 250 | 2.430 |
Why?
|
| Quantitative Trait Loci | 11 | 2022 | 2113 | 1.250 |
Why?
|
| Genomics | 30 | 2024 | 5829 | 1.200 |
Why?
|
| Genes | 14 | 2013 | 1820 | 1.080 |
Why?
|
| Sequence Analysis, DNA | 22 | 2018 | 4739 | 1.060 |
Why?
|
| Databases, Nucleic Acid | 11 | 2009 | 205 | 1.040 |
Why?
|
| Information Storage and Retrieval | 12 | 2010 | 820 | 1.030 |
Why?
|
| DNA, Complementary | 25 | 2014 | 1989 | 1.030 |
Why?
|
| Systems Biology | 11 | 2024 | 481 | 0.940 |
Why?
|
| Database Management Systems | 8 | 2005 | 256 | 0.920 |
Why?
|
| Gene Expression Regulation | 24 | 2022 | 11855 | 0.910 |
Why?
|
| Algorithms | 37 | 2024 | 14025 | 0.870 |
Why?
|
| MicroRNAs | 12 | 2024 | 3758 | 0.860 |
Why?
|
| Neoplasms | 25 | 2023 | 22142 | 0.830 |
Why?
|
| Organ Specificity | 10 | 2020 | 1963 | 0.800 |
Why?
|
| Gene Expression Regulation, Neoplastic | 32 | 2024 | 8531 | 0.770 |
Why?
|
| Sequence Analysis, RNA | 6 | 2020 | 2011 | 0.770 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 13 | 2020 | 3201 | 0.770 |
Why?
|
| Bayes Theorem | 6 | 2024 | 2329 | 0.720 |
Why?
|
| Genome, Human | 19 | 2022 | 4423 | 0.680 |
Why?
|
| Genome | 13 | 2019 | 1738 | 0.630 |
Why?
|
| Breast Neoplasms | 29 | 2024 | 20982 | 0.600 |
Why?
|
| Gene Library | 17 | 2009 | 1054 | 0.560 |
Why?
|
| Reference Standards | 7 | 2017 | 1005 | 0.550 |
Why?
|
| Gene Expression | 14 | 2021 | 7571 | 0.550 |
Why?
|
| Sequence Alignment | 13 | 2009 | 2175 | 0.550 |
Why?
|
| Oncogenes | 2 | 2019 | 1220 | 0.520 |
Why?
|
| Arabidopsis | 6 | 2009 | 466 | 0.510 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 20 | 2010 | 4567 | 0.510 |
Why?
|
| Principal Component Analysis | 9 | 2018 | 942 | 0.490 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2019 | 1057 | 0.490 |
Why?
|
| Colonic Neoplasms | 9 | 2018 | 2527 | 0.490 |
Why?
|
| Biochemistry | 2 | 2014 | 114 | 0.480 |
Why?
|
| User-Computer Interface | 11 | 2017 | 1393 | 0.480 |
Why?
|
| Models, Genetic | 15 | 2024 | 3430 | 0.470 |
Why?
|
| Genome, Plant | 5 | 2007 | 82 | 0.460 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2024 | 2667 | 0.450 |
Why?
|
| Cluster Analysis | 22 | 2014 | 2706 | 0.450 |
Why?
|
| Knowledge Bases | 1 | 2014 | 97 | 0.450 |
Why?
|
| Pharmacogenetics | 3 | 2014 | 675 | 0.430 |
Why?
|
| Microarray Analysis | 8 | 2013 | 748 | 0.430 |
Why?
|
| Genes, Neoplasm | 4 | 2012 | 370 | 0.430 |
Why?
|
| Colorectal Neoplasms | 10 | 2017 | 6919 | 0.420 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 127 | 0.420 |
Why?
|
| Transcription, Genetic | 21 | 2017 | 7571 | 0.420 |
Why?
|
| Transcription Factors | 17 | 2024 | 12101 | 0.420 |
Why?
|
| Human Genome Project | 6 | 2017 | 200 | 0.410 |
Why?
|
| Humans | 201 | 2024 | 761222 | 0.410 |
Why?
|
| Pathology, Molecular | 3 | 2022 | 329 | 0.400 |
Why?
|
| DNA, Plant | 5 | 2003 | 52 | 0.390 |
Why?
|
| Information Dissemination | 4 | 2014 | 1129 | 0.380 |
Why?
|
| Phenotype | 20 | 2022 | 16575 | 0.370 |
Why?
|
| Genes, Plant | 6 | 2007 | 128 | 0.370 |
Why?
|
| Chromosomes, Plant | 4 | 2006 | 21 | 0.360 |
Why?
|
| Zea mays | 4 | 2006 | 110 | 0.360 |
Why?
|
| Plasma | 1 | 2014 | 586 | 0.350 |
Why?
|
| RNA, Messenger | 24 | 2024 | 12747 | 0.350 |
Why?
|
| Osteosarcoma | 4 | 2020 | 896 | 0.340 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2009 | 49 | 0.340 |
Why?
|
| Genome-Wide Association Study | 9 | 2018 | 12676 | 0.340 |
Why?
|
| Internet | 17 | 2017 | 3096 | 0.330 |
Why?
|
| Chromosome Mapping | 17 | 2014 | 4612 | 0.330 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2019 | 17897 | 0.320 |
Why?
|
| Base Sequence | 23 | 2016 | 12404 | 0.310 |
Why?
|
| Models, Biological | 6 | 2017 | 9458 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2019 | 3634 | 0.300 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2022 | 514 | 0.300 |
Why?
|
| Ovarian Neoplasms | 9 | 2019 | 4872 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2019 | 15920 | 0.290 |
Why?
|
| Antineoplastic Agents | 7 | 2018 | 13632 | 0.290 |
Why?
|
| Software Design | 3 | 2004 | 172 | 0.270 |
Why?
|
| DNA Methylation | 10 | 2021 | 4384 | 0.270 |
Why?
|
| Sex Factors | 3 | 2024 | 10553 | 0.270 |
Why?
|
| Reproducibility of Results | 22 | 2022 | 20118 | 0.270 |
Why?
|
| Angiotensin II | 3 | 2017 | 848 | 0.270 |
Why?
|
| Databases, Factual | 8 | 2006 | 7965 | 0.260 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 1830 | 0.260 |
Why?
|
| Mutation | 10 | 2022 | 30004 | 0.260 |
Why?
|
| Molecular Sequence Data | 25 | 2016 | 17598 | 0.260 |
Why?
|
| Models, Statistical | 8 | 2019 | 5081 | 0.250 |
Why?
|
| Medical Subject Headings | 1 | 2005 | 16 | 0.250 |
Why?
|
| Epidemiology | 2 | 2019 | 280 | 0.250 |
Why?
|
| Patents as Topic | 1 | 2006 | 111 | 0.240 |
Why?
|
| Gene Silencing | 2 | 2010 | 1495 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 9 | 2014 | 6067 | 0.240 |
Why?
|
| Animals | 76 | 2024 | 168089 | 0.240 |
Why?
|
| PubMed | 1 | 2005 | 129 | 0.240 |
Why?
|
| Eukaryotic Cells | 2 | 2005 | 192 | 0.240 |
Why?
|
| Biomedical Research | 2 | 2017 | 3434 | 0.230 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 325 | 0.230 |
Why?
|
| Protein Interaction Mapping | 3 | 2017 | 614 | 0.230 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2005 | 330 | 0.230 |
Why?
|
| Bone Neoplasms | 4 | 2020 | 2527 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 8 | 2018 | 2691 | 0.220 |
Why?
|
| Cattle | 5 | 2005 | 3818 | 0.220 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 3 | 2013 | 158 | 0.210 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2015 | 459 | 0.210 |
Why?
|
| Arabidopsis Proteins | 1 | 2005 | 264 | 0.210 |
Why?
|
| Oncorhynchus mykiss | 1 | 2003 | 20 | 0.210 |
Why?
|
| Vocabulary, Controlled | 5 | 2013 | 167 | 0.210 |
Why?
|
| Signal Transduction | 17 | 2018 | 23419 | 0.210 |
Why?
|
| Bacterial Proteins | 4 | 2021 | 3836 | 0.210 |
Why?
|
| DNA Mutational Analysis | 5 | 2017 | 4107 | 0.210 |
Why?
|
| Ovary | 2 | 2019 | 957 | 0.200 |
Why?
|
| Publishing | 3 | 2004 | 832 | 0.200 |
Why?
|
| Consensus Sequence | 5 | 2005 | 362 | 0.200 |
Why?
|
| Prognosis | 21 | 2024 | 29688 | 0.200 |
Why?
|
| Viral Proteins | 4 | 2013 | 1798 | 0.200 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2021 | 1131 | 0.200 |
Why?
|
| Mice | 38 | 2020 | 81330 | 0.200 |
Why?
|
| Quality Control | 4 | 2017 | 833 | 0.190 |
Why?
|
| Vibrio | 1 | 2001 | 40 | 0.190 |
Why?
|
| Proteome | 4 | 2008 | 1856 | 0.190 |
Why?
|
| Paraffin Embedding | 6 | 2017 | 302 | 0.190 |
Why?
|
| Milk Proteins | 1 | 2002 | 162 | 0.190 |
Why?
|
| Molecular Sequence Annotation | 4 | 2017 | 518 | 0.190 |
Why?
|
| Nucleic Acid Hybridization | 6 | 2008 | 1301 | 0.190 |
Why?
|
| Lung | 10 | 2024 | 9979 | 0.190 |
Why?
|
| Epithelial Cells | 6 | 2013 | 3671 | 0.190 |
Why?
|
| RNA, Neoplasm | 4 | 2017 | 748 | 0.190 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2015 | 340 | 0.190 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2021 | 27 | 0.190 |
Why?
|
| RNA | 9 | 2011 | 2709 | 0.180 |
Why?
|
| Paenibacillus | 1 | 2020 | 16 | 0.180 |
Why?
|
| Sequence Tagged Sites | 4 | 1997 | 96 | 0.180 |
Why?
|
| Exosomes | 2 | 2017 | 424 | 0.180 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 272 | 0.180 |
Why?
|
| Female | 71 | 2024 | 392552 | 0.180 |
Why?
|
| Cyclin D1 | 2 | 2014 | 451 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2897 | 0.170 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2452 | 0.170 |
Why?
|
| Research Design | 7 | 2012 | 6180 | 0.170 |
Why?
|
| Cell Line | 15 | 2017 | 15545 | 0.170 |
Why?
|
| Editorial Policies | 1 | 2004 | 458 | 0.170 |
Why?
|
| Formaldehyde | 5 | 2017 | 357 | 0.170 |
Why?
|
| Survival Analysis | 12 | 2020 | 10088 | 0.170 |
Why?
|
| Systems Integration | 2 | 2017 | 428 | 0.170 |
Why?
|
| Stem Cells | 2 | 2009 | 3517 | 0.170 |
Why?
|
| Loss of Heterozygosity | 2 | 2012 | 662 | 0.170 |
Why?
|
| Pleural Neoplasms | 2 | 2015 | 609 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2021 | 164 | 0.160 |
Why?
|
| Glioblastoma | 4 | 2021 | 3482 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 4 | 2012 | 1076 | 0.160 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2001 | 403 | 0.160 |
Why?
|
| Tissue Fixation | 4 | 2017 | 241 | 0.160 |
Why?
|
| Data Collection | 2 | 2006 | 3320 | 0.160 |
Why?
|
| Artificial Intelligence | 4 | 2020 | 2576 | 0.160 |
Why?
|
| RNA, Untranslated | 4 | 2013 | 453 | 0.160 |
Why?
|
| DNA Repair | 4 | 2021 | 2041 | 0.150 |
Why?
|
| Receptors, Estrogen | 6 | 2014 | 2208 | 0.150 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2017 | 6 | 0.150 |
Why?
|
| Cell Line, Tumor | 14 | 2024 | 16954 | 0.150 |
Why?
|
| Pluripotent Stem Cells | 2 | 2016 | 794 | 0.150 |
Why?
|
| Sleep Medicine Specialty | 1 | 2019 | 71 | 0.150 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2640 | 0.150 |
Why?
|
| RNA Interference | 2 | 2021 | 2816 | 0.150 |
Why?
|
| Mesothelioma | 2 | 2015 | 807 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 1995 | 410 | 0.150 |
Why?
|
| Genes, Bacterial | 1 | 2001 | 1073 | 0.150 |
Why?
|
| Apoptosis | 4 | 2010 | 9478 | 0.150 |
Why?
|
| Lung Neoplasms | 5 | 2017 | 13386 | 0.150 |
Why?
|
| Glycolysis | 2 | 2016 | 836 | 0.150 |
Why?
|
| Proteomics | 4 | 2008 | 3840 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
| Computer Simulation | 6 | 2023 | 6224 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 8 | 2013 | 5773 | 0.140 |
Why?
|
| Databases as Topic | 2 | 2017 | 473 | 0.140 |
Why?
|
| Cell Transformation, Viral | 2 | 2016 | 526 | 0.140 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2002 | 1053 | 0.140 |
Why?
|
| Neutrophils | 1 | 2009 | 3763 | 0.140 |
Why?
|
| Gene Expression Regulation, Plant | 4 | 2009 | 211 | 0.140 |
Why?
|
| Toxicogenetics | 2 | 2008 | 19 | 0.140 |
Why?
|
| Lung Diseases | 5 | 2007 | 1910 | 0.140 |
Why?
|
| Area Under Curve | 3 | 2018 | 1636 | 0.140 |
Why?
|
| Pulmonary Medicine | 1 | 2019 | 221 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2006 | 1222 | 0.130 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 1246 | 0.130 |
Why?
|
| Phylogeny | 4 | 2021 | 2809 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2017 | 2926 | 0.130 |
Why?
|
| Biostatistics | 1 | 2018 | 164 | 0.130 |
Why?
|
| Cell Differentiation | 8 | 2016 | 11512 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2005 | 1163 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2018 | 413 | 0.130 |
Why?
|
| RNA Splicing | 3 | 2013 | 896 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2019 | 1329 | 0.130 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2016 | 257 | 0.130 |
Why?
|
| Species Specificity | 7 | 2007 | 2406 | 0.130 |
Why?
|
| Iron-Binding Proteins | 1 | 2016 | 79 | 0.130 |
Why?
|
| Sample Size | 2 | 2017 | 843 | 0.130 |
Why?
|
| Gene Dosage | 5 | 2010 | 1217 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1089 | 0.130 |
Why?
|
| Carcinoma | 4 | 2010 | 2330 | 0.130 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2017 | 704 | 0.120 |
Why?
|
| Cell Proliferation | 6 | 2014 | 10423 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 323 | 0.120 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 478 | 0.120 |
Why?
|
| Bronchitis | 1 | 2016 | 196 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2015 | 1405 | 0.120 |
Why?
|
| CpG Islands | 2 | 2010 | 1190 | 0.120 |
Why?
|
| Breast | 3 | 2017 | 1964 | 0.120 |
Why?
|
| Information Management | 2 | 2007 | 100 | 0.120 |
Why?
|
| Computer Graphics | 3 | 2013 | 338 | 0.120 |
Why?
|
| Rats | 10 | 2011 | 23705 | 0.120 |
Why?
|
| Iron Chelating Agents | 1 | 2016 | 141 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2013 | 4935 | 0.120 |
Why?
|
| Rest | 1 | 2019 | 920 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2021 | 1014 | 0.120 |
Why?
|
| Alternative Splicing | 4 | 2014 | 1087 | 0.120 |
Why?
|
| Ixodidae | 2 | 2005 | 5 | 0.120 |
Why?
|
| BRCA1 Protein | 1 | 2021 | 1149 | 0.110 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2011 | 121 | 0.110 |
Why?
|
| Reverse Transcription | 1 | 2014 | 47 | 0.110 |
Why?
|
| Transcriptional Activation | 2 | 2017 | 1749 | 0.110 |
Why?
|
| Smoke | 1 | 2016 | 236 | 0.110 |
Why?
|
| Contig Mapping | 2 | 2003 | 54 | 0.110 |
Why?
|
| Conserved Sequence | 3 | 2006 | 1162 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2020 | 764 | 0.110 |
Why?
|
| Mammary Arteries | 1 | 2014 | 81 | 0.110 |
Why?
|
| Validation Studies as Topic | 1 | 2014 | 162 | 0.110 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 3788 | 0.110 |
Why?
|
| Receptor, Notch2 | 1 | 2014 | 88 | 0.110 |
Why?
|
| Male | 39 | 2024 | 360703 | 0.110 |
Why?
|
| Cell Fractionation | 1 | 2014 | 248 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 918 | 0.110 |
Why?
|
| Biology | 2 | 2006 | 290 | 0.110 |
Why?
|
| Cloning, Molecular | 5 | 2003 | 4167 | 0.110 |
Why?
|
| Oxygen | 1 | 2005 | 4228 | 0.110 |
Why?
|
| Reaction Time | 1 | 2019 | 2087 | 0.110 |
Why?
|
| Fallopian Tubes | 1 | 2013 | 178 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2008 | 1900 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2012 | 2475 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 464 | 0.100 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 6341 | 0.100 |
Why?
|
| Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 847 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6486 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2022 | 848 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1264 | 0.100 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2016 | 328 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2024 | 1048 | 0.100 |
Why?
|
| Myocardium | 2 | 2006 | 4746 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 3412 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2017 | 573 | 0.100 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2012 | 34 | 0.100 |
Why?
|
| Plasmodium yoelii | 2 | 2002 | 41 | 0.100 |
Why?
|
| Sialoglycoproteins | 2 | 2003 | 315 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 714 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 3512 | 0.100 |
Why?
|
| Granulosa Cells | 1 | 2012 | 115 | 0.100 |
Why?
|
| Forecasting | 3 | 2008 | 2928 | 0.100 |
Why?
|
| Rectum | 1 | 2016 | 891 | 0.100 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 366 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2019 | 1880 | 0.090 |
Why?
|
| Disease Progression | 9 | 2018 | 13511 | 0.090 |
Why?
|
| Human papillomavirus 16 | 2 | 2012 | 267 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2017 | 1878 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2021 | 1912 | 0.090 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 189 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2015 | 752 | 0.090 |
Why?
|
| Up-Regulation | 6 | 2013 | 4111 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2006 | 781 | 0.090 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 683 | 0.090 |
Why?
|
| Cells | 1 | 2011 | 164 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2014 | 1360 | 0.090 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2014 | 496 | 0.090 |
Why?
|
| DNA Primers | 4 | 2006 | 2814 | 0.090 |
Why?
|
| Databases, Protein | 2 | 2009 | 386 | 0.090 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 194 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2014 | 559 | 0.090 |
Why?
|
| Viral Matrix Proteins | 1 | 2011 | 193 | 0.090 |
Why?
|
| Response Elements | 1 | 2011 | 306 | 0.080 |
Why?
|
| Case-Control Studies | 11 | 2017 | 22174 | 0.080 |
Why?
|
| Middle Aged | 25 | 2021 | 220858 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 495 | 0.080 |
Why?
|
| Smoking | 4 | 2020 | 9055 | 0.080 |
Why?
|
| Genetic Variation | 5 | 2017 | 6567 | 0.080 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 189 | 0.080 |
Why?
|
| Ursidae | 1 | 2009 | 26 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 717 | 0.080 |
Why?
|
| DNA Copy Number Variations | 3 | 2014 | 2024 | 0.080 |
Why?
|
| Neprilysin | 1 | 2012 | 478 | 0.080 |
Why?
|
| Hibernation | 1 | 2009 | 48 | 0.080 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 18222 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15308 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2007 | 2509 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 727 | 0.080 |
Why?
|
| Pineal Gland | 1 | 2009 | 158 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 4404 | 0.080 |
Why?
|
| Chromosomes, Artificial, Yeast | 4 | 1996 | 113 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 9567 | 0.080 |
Why?
|
| Liver Regeneration | 1 | 2010 | 214 | 0.080 |
Why?
|
| Adipocytes | 2 | 2005 | 1190 | 0.080 |
Why?
|
| Sirolimus | 1 | 2015 | 1540 | 0.080 |
Why?
|
| Aged | 20 | 2020 | 169292 | 0.080 |
Why?
|
| Repressor Proteins | 3 | 2016 | 2974 | 0.080 |
Why?
|
| Genetic Markers | 7 | 2014 | 2599 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 3875 | 0.080 |
Why?
|
| Programming Languages | 2 | 2006 | 130 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2013 | 730 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2012 | 709 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 1400 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2011 | 4513 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2014 | 3610 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 142 | 0.070 |
Why?
|
| Epigenomics | 3 | 2020 | 944 | 0.070 |
Why?
|
| SELEX Aptamer Technique | 2 | 2018 | 19 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 9 | 2017 | 22128 | 0.070 |
Why?
|
| Transcription Initiation Site | 2 | 2005 | 187 | 0.070 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 58952 | 0.070 |
Why?
|
| Retinal Neoplasms | 1 | 2009 | 148 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 821 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2017 | 2623 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 2820 | 0.070 |
Why?
|
| Gryllidae | 1 | 2007 | 20 | 0.070 |
Why?
|
| Protein Biosynthesis | 5 | 2009 | 2091 | 0.070 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2007 | 22 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 2636 | 0.070 |
Why?
|
| Iron | 1 | 2016 | 1791 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 582 | 0.070 |
Why?
|
| Coronary Artery Bypass | 2 | 2014 | 2193 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 255 | 0.070 |
Why?
|
| Streptococcus | 1 | 2007 | 197 | 0.070 |
Why?
|
| Asthma | 3 | 2017 | 6230 | 0.070 |
Why?
|
| Brain Neoplasms | 4 | 2021 | 9025 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 2 | 2012 | 1448 | 0.070 |
Why?
|
| Disease | 1 | 2012 | 670 | 0.070 |
Why?
|
| Chromatin | 2 | 2022 | 2946 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2013 | 782 | 0.070 |
Why?
|
| Genes, Duplicate | 1 | 2006 | 30 | 0.070 |
Why?
|
| Vocalization, Animal | 1 | 2007 | 94 | 0.070 |
Why?
|
| Protein Binding | 4 | 2016 | 9297 | 0.070 |
Why?
|
| Antigens, Viral | 1 | 2010 | 989 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2016 | 3031 | 0.070 |
Why?
|
| Open Reading Frames | 5 | 2012 | 811 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 11067 | 0.070 |
Why?
|
| Receptor, erbB-2 | 3 | 2012 | 2553 | 0.070 |
Why?
|
| Virus Diseases | 1 | 2012 | 716 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2018 | 2320 | 0.070 |
Why?
|
| Sequence Homology | 2 | 2003 | 196 | 0.070 |
Why?
|
| Blood Platelets | 2 | 2014 | 2477 | 0.070 |
Why?
|
| Guidelines as Topic | 3 | 2008 | 1385 | 0.060 |
Why?
|
| Critical Care | 1 | 2019 | 2696 | 0.060 |
Why?
|
| Terminator Regions, Genetic | 1 | 2005 | 26 | 0.060 |
Why?
|
| Ploidies | 1 | 2006 | 285 | 0.060 |
Why?
|
| Biflavonoids | 1 | 2005 | 9 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2008 | 958 | 0.060 |
Why?
|
| Vitis | 1 | 2005 | 19 | 0.060 |
Why?
|
| Proanthocyanidins | 1 | 2005 | 20 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1327 | 0.060 |
Why?
|
| ras Proteins | 4 | 2012 | 1055 | 0.060 |
Why?
|
| Genes, Protozoan | 1 | 2005 | 170 | 0.060 |
Why?
|
| Catechin | 1 | 2005 | 69 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 283 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 2635 | 0.060 |
Why?
|
| Theileria parva | 1 | 2004 | 1 | 0.060 |
Why?
|
| Rhipicephalus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Anaerobiosis | 1 | 2005 | 139 | 0.060 |
Why?
|
| Plant Diseases | 2 | 2003 | 180 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1348 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2009 | 3596 | 0.060 |
Why?
|
| Cohort Studies | 9 | 2022 | 41496 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 614 | 0.060 |
Why?
|
| Weight Loss | 1 | 2016 | 2680 | 0.060 |
Why?
|
| Microsatellite Instability | 3 | 2017 | 716 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 5809 | 0.060 |
Why?
|
| Fermentation | 1 | 2005 | 142 | 0.060 |
Why?
|
| Anthrax | 1 | 2005 | 83 | 0.060 |
Why?
|
| Adult | 20 | 2021 | 221120 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2006 | 504 | 0.060 |
Why?
|
| Trans-Activators | 3 | 2011 | 2846 | 0.060 |
Why?
|
| Bacillus anthracis | 1 | 2005 | 118 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2017 | 1746 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5665 | 0.060 |
Why?
|
| Radiology | 1 | 2018 | 2112 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 470 | 0.060 |
Why?
|
| Reference Values | 3 | 2012 | 4921 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 630 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2016 | 221 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2006 | 271 | 0.060 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2004 | 221 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 278 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 506 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 1 | 2005 | 262 | 0.060 |
Why?
|
| Melanoma | 2 | 2013 | 5694 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 2 | 2002 | 183 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3534 | 0.060 |
Why?
|
| Sleep | 1 | 2019 | 4759 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2004 | 2740 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 487 | 0.060 |
Why?
|
| Gene Amplification | 1 | 2008 | 1084 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5869 | 0.060 |
Why?
|
| Plasmodium vivax | 1 | 2005 | 202 | 0.060 |
Why?
|
| Amino Acid Sequence | 7 | 2005 | 13402 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2008 | 719 | 0.050 |
Why?
|
| Plant Structures | 1 | 2003 | 7 | 0.050 |
Why?
|
| Hypermedia | 1 | 2003 | 20 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2013 | 18927 | 0.050 |
Why?
|
| Genetic Testing | 3 | 2016 | 3537 | 0.050 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2003 | 56 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2002 | 1545 | 0.050 |
Why?
|
| Catfishes | 1 | 2003 | 14 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2006 | 428 | 0.050 |
Why?
|
| Genes, Helminth | 1 | 2003 | 146 | 0.050 |
Why?
|
| Salts | 1 | 2003 | 62 | 0.050 |
Why?
|
| Adenoma | 2 | 2005 | 2159 | 0.050 |
Why?
|
| RNA, Plant | 1 | 2002 | 30 | 0.050 |
Why?
|
| Genes, src | 1 | 2002 | 51 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2016 | 1644 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 832 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 145 | 0.050 |
Why?
|
| Multigene Family | 3 | 2002 | 1075 | 0.050 |
Why?
|
| Streptococcal Infections | 1 | 2007 | 617 | 0.050 |
Why?
|
| Genes, Insect | 1 | 2003 | 265 | 0.050 |
Why?
|
| Solanum tuberosum | 1 | 2003 | 46 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 563 | 0.050 |
Why?
|
| Retroelements | 1 | 2003 | 162 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 416 | 0.050 |
Why?
|
| Swine | 2 | 2003 | 5909 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2007 | 702 | 0.050 |
Why?
|
| Mitochondria | 1 | 2016 | 3620 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 1997 | 785 | 0.050 |
Why?
|
| Proteins | 4 | 2011 | 5993 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 286 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2003 | 439 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 1141 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3696 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2018 | 64681 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2006 | 774 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 982 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2003 | 156 | 0.050 |
Why?
|
| Hemin | 1 | 2001 | 51 | 0.050 |
Why?
|
| Hematologic Diseases | 1 | 2006 | 496 | 0.050 |
Why?
|
| Metabolome | 1 | 2009 | 989 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 4909 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2003 | 1682 | 0.050 |
Why?
|
| RNA, Protozoan | 1 | 2001 | 45 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2915 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 4744 | 0.050 |
Why?
|
| Genome, Protozoan | 1 | 2002 | 152 | 0.050 |
Why?
|
| DNA | 4 | 2013 | 7189 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2009 | 1084 | 0.050 |
Why?
|
| Folic Acid | 1 | 2008 | 1323 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2018 | 6819 | 0.050 |
Why?
|
| Cell Lineage | 3 | 2017 | 2549 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2009 | 2916 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2007 | 1882 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2002 | 229 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2024 | 4642 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2965 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 2223 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 2746 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2021 | 83 | 0.050 |
Why?
|
| Genomic Library | 2 | 2006 | 188 | 0.050 |
Why?
|
| Estradiol | 1 | 2008 | 1937 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2021 | 3073 | 0.040 |
Why?
|
| Chickens | 1 | 2003 | 857 | 0.040 |
Why?
|
| Sensitivity and Specificity | 7 | 2013 | 14675 | 0.040 |
Why?
|
| Macrophages | 3 | 2005 | 5755 | 0.040 |
Why?
|
| Models, Theoretical | 3 | 2010 | 3571 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2013 | 11119 | 0.040 |
Why?
|
| Fixatives | 2 | 2012 | 90 | 0.040 |
Why?
|
| DNA Probes | 1 | 2001 | 542 | 0.040 |
Why?
|
| Caspases | 1 | 2003 | 878 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2414 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2016 | 5333 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 396 | 0.040 |
Why?
|
| Synteny | 3 | 2006 | 77 | 0.040 |
Why?
|
| Cell Division | 3 | 2003 | 4451 | 0.040 |
Why?
|
| Leukemia | 1 | 2008 | 1518 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2006 | 2603 | 0.040 |
Why?
|
| Genotype | 4 | 2022 | 12985 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2001 | 393 | 0.040 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7851 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2894 | 0.040 |
Why?
|
| Survival Rate | 3 | 2021 | 12728 | 0.040 |
Why?
|
| Chromosomes, Mammalian | 3 | 2005 | 147 | 0.040 |
Why?
|
| Microdissection | 1 | 2019 | 151 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2003 | 838 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1728 | 0.040 |
Why?
|
| Documentation | 1 | 2006 | 900 | 0.040 |
Why?
|
| Hot Temperature | 2 | 2003 | 1434 | 0.040 |
Why?
|
| Cholesterol | 1 | 2008 | 2902 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 346 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2003 | 783 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2019 | 272 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 731 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2021 | 267 | 0.040 |
Why?
|
| Metabolomics | 2 | 2019 | 1658 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2656 | 0.040 |
Why?
|
| Recombination, Genetic | 4 | 2011 | 1518 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 987 | 0.040 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 2 | 2012 | 23 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2014 | 6635 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4021 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5301 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2024 | 2813 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6223 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2006 | 1528 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2021 | 8300 | 0.040 |
Why?
|
| Archaeoglobus fulgidus | 1 | 1997 | 6 | 0.040 |
Why?
|
| Genes, Archaeal | 1 | 1997 | 8 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 320 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 30 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1240 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 2007 | 1762 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1912 | 0.040 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2017 | 23 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 2 | 2014 | 929 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2189 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 1301 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2016 | 790 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 734 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 794 | 0.040 |
Why?
|
| Cell Wall | 1 | 2021 | 417 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1997 | 97 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2013 | 864 | 0.040 |
Why?
|
| Biopsy | 2 | 2020 | 6781 | 0.040 |
Why?
|
| Heart Diseases | 2 | 2013 | 2795 | 0.040 |
Why?
|
| Young Adult | 6 | 2021 | 59222 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 2293 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2009 | 1640 | 0.040 |
Why?
|
| Parturition | 1 | 2021 | 447 | 0.040 |
Why?
|
| Dogs | 2 | 2017 | 3832 | 0.040 |
Why?
|
| Viruses | 1 | 2021 | 372 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1228 | 0.040 |
Why?
|
| Activin Receptors, Type I | 1 | 2018 | 134 | 0.040 |
Why?
|
| Antioxidants | 1 | 2005 | 1667 | 0.040 |
Why?
|
| Immunity, Innate | 3 | 2007 | 3044 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2867 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 1616 | 0.040 |
Why?
|
| Utah | 1 | 2017 | 130 | 0.040 |
Why?
|
| Hybrid Cells | 1 | 1997 | 421 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6125 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3493 | 0.030 |
Why?
|
| DNA Damage | 2 | 2021 | 2443 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2017 | 210 | 0.030 |
Why?
|
| ROC Curve | 2 | 2017 | 3584 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3813 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 1997 | 160 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 3778 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2199 | 0.030 |
Why?
|
| Neural Plate | 1 | 2016 | 11 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2002 | 801 | 0.030 |
Why?
|
| Liver | 2 | 2009 | 7512 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2016 | 103 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2007 | 2888 | 0.030 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2016 | 42 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 1666 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 353 | 0.030 |
Why?
|
| Mice, Knockout | 4 | 2016 | 14392 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 151 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2016 | 210 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 706 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 80 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2012 | 1129 | 0.030 |
Why?
|
| Uganda | 1 | 2020 | 1332 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5321 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 190 | 0.030 |
Why?
|
| Time Factors | 3 | 2009 | 39957 | 0.030 |
Why?
|
| Frozen Sections | 2 | 2009 | 153 | 0.030 |
Why?
|
| Adolescent | 6 | 2021 | 88300 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 292 | 0.030 |
Why?
|
| Environment | 1 | 2021 | 1122 | 0.030 |
Why?
|
| 3T3-L1 Cells | 2 | 2005 | 208 | 0.030 |
Why?
|
| Cryopreservation | 2 | 2013 | 728 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1997 | 442 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 3222 | 0.030 |
Why?
|
| Iron, Dietary | 1 | 2016 | 148 | 0.030 |
Why?
|
| Ligands | 2 | 2018 | 3264 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2803 | 0.030 |
Why?
|
| Child | 5 | 2021 | 80154 | 0.030 |
Why?
|
| Airway Remodeling | 1 | 2016 | 132 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2003 | 1390 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 295 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 239 | 0.030 |
Why?
|
| Automation | 2 | 2008 | 585 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3032 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3590 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 1716 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 1453 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15841 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 1159 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2013 | 3603 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 367 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2007 | 3594 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2011 | 314 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2016 | 617 | 0.030 |
Why?
|
| Research | 1 | 2002 | 1976 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3366 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9327 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12940 | 0.030 |
Why?
|
| Emphysema | 1 | 2016 | 238 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2016 | 299 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 1997 | 382 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 696 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4947 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1855 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4014 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 182 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2021 | 3446 | 0.030 |
Why?
|
| RNA, Antisense | 2 | 2005 | 136 | 0.030 |
Why?
|
| DNA, Protozoan | 2 | 2005 | 228 | 0.030 |
Why?
|
| Callithrix | 1 | 2013 | 95 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1994 | 321 | 0.030 |
Why?
|
| Transfection | 2 | 2016 | 5748 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 874 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1318 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 361 | 0.030 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2013 | 31 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2012 | 4340 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 193 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 673 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 620 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2013 | 105 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2011 | 6930 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1889 | 0.030 |
Why?
|
| Receptors, LH | 1 | 2012 | 18 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 2014 | 2340 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Sputum | 1 | 2014 | 505 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 993 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 450 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2012 | 326 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 244 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1743 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Mucus | 1 | 2013 | 342 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 944 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1988 | 0.020 |
Why?
|
| Polyomavirus | 1 | 2012 | 234 | 0.020 |
Why?
|
| Comet Assay | 1 | 2011 | 75 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10203 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2005 | 457 | 0.020 |
Why?
|
| Zebrafish | 1 | 2003 | 3000 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8702 | 0.020 |
Why?
|
| Binding Sites | 2 | 2013 | 5988 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 2013 | 271 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2011 | 162 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5406 | 0.020 |
Why?
|
| Lung Injury | 1 | 2016 | 422 | 0.020 |
Why?
|
| DNA Fingerprinting | 2 | 2005 | 114 | 0.020 |
Why?
|
| Osteopontin | 2 | 2003 | 302 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 371 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 20588 | 0.020 |
Why?
|
| United States | 6 | 2019 | 72341 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 883 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 252 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 651 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 2004 | 4243 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 254 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1967 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2010 | 2054 | 0.020 |
Why?
|
| Fanconi Anemia | 1 | 2012 | 324 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2012 | 726 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2013 | 771 | 0.020 |
Why?
|
| Amino Acid Motifs | 2 | 2002 | 924 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 436 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 1994 | 0.020 |
Why?
|
| Markov Chains | 1 | 2013 | 965 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 4310 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10756 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2012 | 407 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2009 | 109 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2017 | 1465 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2009 | 203 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2010 | 139 | 0.020 |
Why?
|
| Attention | 1 | 2019 | 2394 | 0.020 |
Why?
|
| Immunological Synapses | 1 | 2009 | 58 | 0.020 |
Why?
|
| Choline Kinase | 1 | 2008 | 5 | 0.020 |
Why?
|
| Bronchi | 1 | 2013 | 843 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1005 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36170 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9429 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 830 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 8606 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3803 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 775 | 0.020 |
Why?
|
| Vimentin | 1 | 2009 | 255 | 0.020 |
Why?
|
| DNA, Bacterial | 3 | 1997 | 1470 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1075 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Ribosomes | 1 | 2011 | 494 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1892 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2008 | 57 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2569 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2008 | 224 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2009 | 649 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 2 | 2000 | 280 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 610 | 0.020 |
Why?
|
| Receptors, Erythropoietin | 1 | 2008 | 144 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2009 | 161 | 0.020 |
Why?
|
| Kainic Acid | 1 | 2008 | 203 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1132 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2009 | 231 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 42225 | 0.020 |
Why?
|
| Stroke | 1 | 2010 | 9721 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 486 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 317 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 230 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2012 | 743 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 671 | 0.020 |
Why?
|
| Trachea | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2011 | 665 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3606 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 382 | 0.020 |
Why?
|
| Brain | 2 | 2014 | 27094 | 0.020 |
Why?
|
| Hawaii | 1 | 2007 | 101 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2007 | 38 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 826 | 0.020 |
Why?
|
| tau Proteins | 1 | 2018 | 2094 | 0.020 |
Why?
|
| Nurses | 1 | 2017 | 2477 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 9520 | 0.020 |
Why?
|
| Oocytes | 1 | 2012 | 1165 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2013 | 1594 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2009 | 410 | 0.020 |
Why?
|
| Health Surveys | 1 | 2017 | 4037 | 0.020 |
Why?
|
| Cricetinae | 2 | 2003 | 2412 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11733 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3923 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1381 | 0.020 |
Why?
|
| Inflammation | 1 | 2006 | 10759 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2006 | 34 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 2040 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 1031 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 12052 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2012 | 1120 | 0.020 |
Why?
|
| Neurobiology | 1 | 2007 | 137 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 231 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 1002 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2009 | 693 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 123 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2012 | 761 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2005 | 29 | 0.020 |
Why?
|
| Genes, DCC | 1 | 2005 | 10 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2006 | 129 | 0.020 |
Why?
|
| Body Temperature | 1 | 2009 | 780 | 0.020 |
Why?
|
| Virulence | 2 | 2001 | 1296 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6200 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1967 | 0.020 |
Why?
|
| Fluorescence | 1 | 2008 | 751 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 724 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2020 | 5921 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2011 | 937 | 0.020 |
Why?
|
| Classification | 1 | 2006 | 128 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 135 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 344 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5871 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3091 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1751 | 0.020 |
Why?
|
| Homocysteine | 1 | 2008 | 637 | 0.020 |
Why?
|
| Cosmids | 2 | 1995 | 105 | 0.020 |
Why?
|
| District of Columbia | 1 | 2005 | 159 | 0.020 |
Why?
|
| Seeds | 1 | 2005 | 122 | 0.020 |
Why?
|
| Arachnid Vectors | 1 | 2004 | 24 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 2005 | 156 | 0.020 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2004 | 20 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 5366 | 0.010 |
Why?
|
| History, 18th Century | 1 | 2005 | 206 | 0.010 |
Why?
|
| Baltimore | 1 | 2005 | 231 | 0.010 |
Why?
|
| Risk Assessment | 4 | 2009 | 24022 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18384 | 0.010 |
Why?
|
| Cadherins | 1 | 2009 | 902 | 0.010 |
Why?
|
| Glucose | 1 | 2016 | 4342 | 0.010 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 113 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2008 | 1848 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1720 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 671 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 209 | 0.010 |
Why?
|
| Pneumonia | 1 | 2016 | 2142 | 0.010 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 886 | 0.010 |
Why?
|
| Telomere | 2 | 2002 | 939 | 0.010 |
Why?
|
| Biotechnology | 1 | 2006 | 281 | 0.010 |
Why?
|
| Thalidomide | 1 | 2009 | 885 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2003 | 29 | 0.010 |
Why?
|
| Risk Factors | 3 | 2021 | 74241 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39127 | 0.010 |
Why?
|
| Malaria, Vivax | 1 | 2005 | 166 | 0.010 |
Why?
|
| DNA, Helminth | 1 | 2003 | 35 | 0.010 |
Why?
|
| Phytophthora | 1 | 2003 | 5 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2731 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2003 | 48 | 0.010 |
Why?
|
| Chromosomes, Artificial | 1 | 2003 | 3 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2003 | 69 | 0.010 |
Why?
|
| Plant Stems | 1 | 2003 | 19 | 0.010 |
Why?
|
| Survivors | 1 | 2014 | 2369 | 0.010 |
Why?
|
| Cathepsin D | 1 | 2003 | 59 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 514 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
| Genes, Essential | 1 | 2004 | 185 | 0.010 |
Why?
|
| Ethics Committees, Research | 1 | 2004 | 196 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 452 | 0.010 |
Why?
|
| Pregnancy | 2 | 2021 | 29893 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2003 | 181 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1676 | 0.010 |
Why?
|
| Histones | 1 | 2013 | 2570 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12474 | 0.010 |
Why?
|
| Base Composition | 1 | 2002 | 290 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2005 | 483 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2019 | 80675 | 0.010 |
Why?
|
| Information Systems | 1 | 2004 | 396 | 0.010 |
Why?
|
| Foam Cells | 1 | 2002 | 68 | 0.010 |
Why?
|
| Plasmodium falciparum | 2 | 2002 | 1740 | 0.010 |
Why?
|
| Cathepsins | 1 | 2003 | 241 | 0.010 |
Why?
|
| Ribosomal Proteins | 1 | 2004 | 370 | 0.010 |
Why?
|
| Cognition | 1 | 2019 | 6988 | 0.010 |
Why?
|
| Rheology | 1 | 2003 | 347 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 623 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 914 | 0.010 |
Why?
|
| Fasting | 1 | 2008 | 1603 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2047 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4243 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1347 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 782 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4190 | 0.010 |
Why?
|
| Endothelium | 1 | 2004 | 763 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2005 | 573 | 0.010 |
Why?
|
| Periodicals as Topic | 2 | 2002 | 1463 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8998 | 0.010 |
Why?
|
| Laboratories | 1 | 2005 | 462 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2005 | 896 | 0.010 |
Why?
|
| Plants | 1 | 2003 | 329 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26200 | 0.010 |
Why?
|
| Rodentia | 1 | 2002 | 261 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4138 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 597 | 0.010 |
Why?
|
| Mastectomy | 1 | 2009 | 1818 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1067 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 54437 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2003 | 374 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 551 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2006 | 1767 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 833 | 0.010 |
Why?
|
| Malaria Vaccines | 1 | 2001 | 163 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2006 | 930 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5478 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2478 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2263 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2854 | 0.010 |
Why?
|
| Enzymes | 1 | 2001 | 252 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2001 | 301 | 0.010 |
Why?
|
| Anopheles | 1 | 2001 | 192 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2006 | 2658 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1703 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 746 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2004 | 974 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2223 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1651 | 0.010 |
Why?
|
| International Cooperation | 1 | 2004 | 1423 | 0.010 |
Why?
|
| Replication Origin | 1 | 1997 | 77 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6586 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 855 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12976 | 0.010 |
Why?
|
| Triglycerides | 1 | 2005 | 2457 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 1838 | 0.010 |
Why?
|
| Antigenic Variation | 1 | 1997 | 118 | 0.010 |
Why?
|
| Diploidy | 1 | 1997 | 133 | 0.010 |
Why?
|
| Pyridones | 1 | 2002 | 809 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 8164 | 0.010 |
Why?
|
| Hypertension | 1 | 1997 | 8536 | 0.010 |
Why?
|
| Risk | 1 | 2009 | 9616 | 0.010 |
Why?
|
| Energy Metabolism | 2 | 1997 | 2877 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 1997 | 304 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2359 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1140 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 2410 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1506 | 0.010 |
Why?
|
| Protozoan Proteins | 1 | 2001 | 846 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 1994 | 26 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 295 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1997 | 598 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1994 | 66 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1994 | 260 | 0.010 |
Why?
|
| Lipids | 1 | 2005 | 3331 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 1994 | 104 | 0.010 |
Why?
|
| Fetus | 1 | 2001 | 1864 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2081 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8519 | 0.010 |
Why?
|
| Malaria | 1 | 2002 | 1225 | 0.010 |
Why?
|
| Kidney | 1 | 2008 | 7033 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2478 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2261 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Sodium | 1 | 1997 | 1589 | 0.010 |
Why?
|
| Lyme Disease | 1 | 1997 | 631 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1997 | 1075 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9278 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2002 | 3027 | 0.010 |
Why?
|
| Diet | 1 | 2008 | 8048 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36415 | 0.000 |
Why?
|